SNSE

Sensei Biotherapeutics, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Peyer James10 Percent Owner, Other: See Remarks Below
$55342 shares
SellDec 5, 2025
$13.16
--
Peyer James10 Percent Owner, Other: See Remarks Below
$21k1.7k shares
SellDec 5, 2025
$12.29
--
Peyer James10 Percent Owner, Other: See Remarks Below
$165k14.5k shares
SellDec 5, 2025
$11.40
--
Peyer James10 Percent Owner, Other: See Remarks Below
$45k5k shares
SellDec 4, 2025
$9.06
--
Cambrian BioPharma Inc10 Percent Owner
$55342 shares
SellDec 5, 2025
$13.16
--
Cambrian BioPharma Inc10 Percent Owner
$21k1.7k shares
SellDec 5, 2025
$12.29
--

News

businesswire.comSensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancerbusinesswire.comJun 15gurufocus.comSensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)gurufocus.comJun 4businesswire.comSensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)businesswire.comJun 4gurufocus.comSensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updategurufocus.comMay 15businesswire.comSensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updatebusinesswire.comMay 15